These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31880526)

  • 1. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02.
    Arken N
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):78-83. PubMed ID: 30782299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
    Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
    Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
    Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid].
    Yu XN; Li H; Chen XL; Li XX; Wang R; Gao F
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):381-4. PubMed ID: 21122352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
    Zou L; Fang Y; He W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
    Li BR; Wang L; Han WN; Xia LQ; Tang S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
    Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line].
    Chen BA; Wang F; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Xia GH; Shan XY
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):389-93. PubMed ID: 21122354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
    Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts.
    Ji M; Shi Y; Lou H
    Biosci Trends; 2011; 5(5):192-7. PubMed ID: 22101374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
    Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
    Qiu Q; Shi W; Li Z; Zhang B; Pan M; Cui J; Dai Y; Huang W; Qian H
    J Med Chem; 2017 Apr; 60(7):2930-2943. PubMed ID: 28301155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.